Mirrors of Medicine· @mirrorsmed · X·· 2 天前评分70
正文 · 原文
🔎 New phase III MIBC data at #ESMO26:
• KEYNOTE-866: perioperative PEMBRO vs perioperative PBO, plus neoadjuvant GC
• CA017-078: perioperative NIVO vs no treatment, plus neoadjuvant GC
• 📊 Both showed numerically higher pCR, but not statistically significant
• No significant improvement in EFS
💡 Take-home: These data do not support a change in current clinical practice.
#BladderCancer #MIBC
335 浏览 · 9 赞 · 5 转发 · 0 回复
会议摘要
4735O按 Proffered paper 1: Genitourinary tumour, renal and urothelial 对上
Perioperative pembrolizumab (pembro) or placebo (pbo) + neoadjuvant cisplatin (cis) and gemcitabine (gem) in participants (pts) with muscle-invasive bladder cancer (MIBC): the double-blind, phase 3 KEYNOTE-866 study
https://esmocongress.esmo.org来源：Mirrors of Medicine · x.com